Objectives: The incidence of antimicrobial resistance in Europe is rising. Cefiderocol is approved in Eu- rope for treatment of aerobic Gram-negative bacterial (GNB) infections in adults with limited treatment options. We report the in vitro activity of cefiderocol versus comparators against GNB clinical isolates from Spain. Methods: MICs were...
-
December 7, 2022 (v1)PublicationUploaded on: March 24, 2023
-
July 14, 2022 (v1)Publication
ackground Rapid and widespread increases in carbapenem resistance (CR) necessitate identification of risk factors to guide appropriate interventions. Objectives We aimed to identify risk factors for CR Gram-negative infection through a systematic literature review. Data sources We searched MEDLINE (via OvidSP and PubMed) and Embase (via...
Uploaded on: March 25, 2023